Prognostic implications of circumferential location of distal rectal cancer

Colorectal Disease

Volumn 13, Issue 6, 2011, Pages 650-657

  Garcia Granero E ^a   Faiz, O ^a   Flor Lorente, B ^a   Garcia Botello S ^a   Esclapez P ^a   Cervantes, A ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Circumferential Resection Margin (CRM); Rectal cancer; Rectal ultrasound; Tumor position

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SURGERY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RECTUM CANCER; RECURRENCE RISK;

AGED; ENDOSONOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RECTAL NEOPLASMS; RISK FACTORS; TREATMENT OUTCOME;

EID: 79955893058     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2010.02249.x     Document Type: Article

References (26)

1. Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 1998; 133: 894-9.
2. Wibe A, Møller B, Norstein J et al. A national strategic change in treatment policy for rectal cancer - implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 2002; 45: 857-66.
3. Kapiteijn E, Putter H, van de Velde CJ. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br J Surg 2002; 89: 1142-9.
4. Wibe A, Eriksen MT, Syse A, Myrvold HE, Soreide O. Total mesorectal excision for rectal cancer--what can be achieved by a national audit? Colorectal Dis 2003; 5: 471-7.
5. Martling A, Cedermark B, Johansson H, Rutqvist LE, Holm T. The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer. Br J Surg 2002; 89: 1008-13.
6. Boyle KM, Sasapu K, Chalmers AG, Sagar PM, Finan PJ, Burke D. Mode of CRM involvement according to location in the mesorectum. Colorectal Dis 2004; 6(Suppl. 1).
7. den Dulk M, Marijnen CA, Putter H et al. Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial. Ann Surg 2007; 246: 83-90.
8. Heald RJ, Moran BJ, Brown G, Daniels IR. Optimal total mesorectal excision for rectal cancer is by dissection in front of Denonvilliers' fascia. Br J Surg 2004; 91: 121-3.
9. Lindsey I, Guy RJ, Warren BF, Mortensen NJ. Anatomy of Denonvilliers' fascia and pelvic nerves, impotence, and implications for the colorectal surgeon. Br J Surg 2000; 87: 1288-99.
10. Killingback M, Barron P, Dent OF. Local recurrence after curative resection of cancer of the rectum without total mesorectal excision. Dis Colon Rectum 2001; 44: 473-83; discussion 83-6.
11. Emslie J, Beart R, Mohiuddin M, Marks G. Use of rectal cancer position as a prognostic indicator. Am Surg 1998; 64: 958-61.
12. Lee SH, Hernandez de Anda E, Finne CO, Madoff RD, Garcia-Aguilar J. The effect of circumferential tumor location in clinical outcomes of rectal cancer patients treated with total mesorectal excision. Dis Colon Rectum 2005; 48: 2249-57.
13. Chan CL, Bokey EL, Chapuis PH, Renwick AA, Dent OF. Local recurrence after curative resection for rectal cancer is associated with anterior position of the tumour. Br J Surg 2006; 93: 105-12.
14. Hildebrandt U, Feifel G. Preoperative staging of rectal cancer by intrarectal ultrasound. Dis Colon Rectum 1985; 28: 42-6.
15. Garcia-Granero E, Marti-Obiol R, Gomez-Barbadillo J et al. Impact of surgeon organization and specialization in rectal cancer outcome. Colorectal Dis 2001; 3: 179-84.
16. Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986; 2: 996-9.
17. Quirke P (1997) Limitation of existing system of staging for rectal cancer: the forgotten margin. In: Rectal Cancer Surgery Optimisation-Standardisation-Documentation (ed. Soreide ONJ), pp. 63-81. Springer, Berlin, Heidelberg, New York.
18. Nagtegaal ID, van de Velde CJ, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 2002; 20: 1729-34.
19. Garcia-Granero E, Faiz O, Munoz E et al. Macroscopic assessment of mesorectal excision in rectal cancer: a useful tool for improving quality control in a multidisciplinary team. Cancer 2009; 115: 3400-11.
20. Sailer M, Leppert R, Bussen D, Fuchs KH, Thiede A. Influence of tumor position on accuracy of endorectal ultrasound staging. Dis Colon Rectum 1997; 40: 1180-6.
21. Phang PT. Total mesorectal excision: technical aspects. Can J Surg 2004; 47: 130-7.
22. Marr R, Birbeck K, Garvican J et al. The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg 2005; 242: 74-82.
23. Maslekar S, Sharma A, Macdonald A, Gunn J, Monson JR, Hartley JE. Mesorectal grades predict recurrences after curative resection for rectal cancer. Dis Colon Rectum 2007; 50: 168-75.
24. West NP, Finan PJ, Anderin C, Lindholm J, Holm T, Quirke P. Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer. J Clin Oncol 2008; 26: 3517-22.
25. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993; 341: 457-60.
26. Buhre LM, Mulder NH, de Ruiter AJ, van Loon AJ, Verschueren RC. Effect of extent of anterior resection and sex on disease-free survival and local recurrence in patients with rectal cancer. Br J Surg 1994; 81: 1227-9.